Key result
Induction of monomorphic VT during programmed electrical stimulation was associated with a significantly higher rate of appropriate AICD therapies compared to induction of VF (48% vs 25%, p=0.02).
Why the study?
Does the induction of monomorphic VT compared to VF during programmed electrical stimulation predict appropriate AICD therapy in high-risk patients?
Cohort (n=102)
Does the induction of monomorphic VT compared to VF during programmed electrical stimulation predict appropriate AICD therapy in high-risk patients?
Absolute Event Rate: 48% vs 25%
p-value: p=0.02
Induction of ventricular fibrillation during programmed electrical stimulation has no prognostic value for predicting appropriate AICD therapy in high-risk patients, whereas induction of monomorphic VT is predictive.
Monomorphic VT induction may identify higher-risk patients for AICD therapies unlike VF; hypothesis-generating for refined risk stratification.
OBJECTIVE: To investigate the prognostic value of induced monomorphic ventricular tachycardia (VT) and ventricular flutter or fibrillation (VF) during programmed electrical stimulation in patients with a high risk for sudden arrhythmogenic cardiac death. DESIGN: Prospective cohort study. PATIENTS: 102 patients at high risk for arrhythmogenic sudden cardiac death who received an automated implantable cardioverter-defibrillator (AICD) were evaluated. 56 patients received the AICD for primary prevention and 46 for secondary prevention. 58 patients had induction of a monomorphic VT (VT group) and 44 had induction of a polymorphic VT, ventricular flutter, or ventricular fibrillation (VF group) during programmed electrical stimulation. Average follow up was 20 months in both groups. MAIN OUTCOME MEASURES: Appropriate AICD protocol. RESULTS: In patients who received the AICD for primary prevention, 16 of 32 patients in the VT group, compared with only four of 24 patients in the VF group, received an appropriate AICD protocol (p = 0.02). In the entire study population, 479 appropriate AICD protocols were recorded in 28 (48%) patients in the VT group and 28 appropriate protocols in 11 (25%) patients in the VF group. Cumulative Kaplan-Meier event-free survival curves were significantly different (p = 0.02). CONCLUSION: Induction of VF during programmed electrical stimulation is of no prognostic value even in high risk patients without previously documented ventricular fibrillation.
No takes yet. Share an insight, caveat, or question.
Matthias Meyborg (2003) conducted a cohort in High risk for sudden arrhythmogenic cardiac death (n=102). Induction of monomorphic ventricular tachycardia (VT) vs. Induction of polymorphic VT, ventricular flutter, or ventricular fibrillation (VF) was evaluated on Appropriate AICD protocol (p=0.02). Induction of monomorphic VT during programmed electrical stimulation was associated with a significantly higher rate of appropriate AICD therapies compared to induction of VF (48% vs 25%, p=0.02).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: